{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:24:03Z","timestamp":1792221843951,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mechanisms underlying liver disease in patients with COVID-19 are not entirely known. The aim is to investigate, by means of novel statistical techniques, the changes over time in the relationship between inflammation markers and liver damage markers in relation to survival in COVID-19. The study included 221 consecutive patients admitted to the hospital during the first COVID-19 wave in Spain. Generalized additive mixed models were used to investigate the influence of time and inflammation markers on liver damage markers in relation to survival. Joint modeling regression was used to evaluate the temporal correlations between inflammation markers (serum C-reactive protein [CRP], interleukin-6, plasma D-dimer, and blood lymphocyte count) and liver damage markers, after adjusting for age, sex, and therapy. The patients who died showed a significant elevation in serum aspartate transaminase (AST) and alkaline phosphatase levels over time. Conversely, a decrease in serum AST levels was observed in the survivors, who showed a negative correlation between inflammation markers and liver damage markers (CRP with serum AST, alanine transaminase [ALT], and gamma-glutamyl transferase [GGT]; and D-dimer with AST and ALT) after a week of hospitalization. Conversely, most correlations were positive in the patients who died, except lymphocyte count, which was negatively correlated with AST, GGT, and alkaline phosphatase. These correlations were attenuated with age. The patients who died during COVID-19 infection displayed a significant elevation of liver damage markers, which is correlated with inflammation markers over time. These results are consistent with the role of systemic inflammation in liver damage during COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-022-09290-x","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:26:56Z","timestamp":1648823216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach"],"prefix":"10.1038","volume":"12","author":[{"given":"Carla","family":"Diaz-Louzao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Barrera-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lopez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Casar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Vazquez-Agra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadrian","family":"Pernas-Pardavila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marques-Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vidal-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna H.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Fernandez-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Gonzalez-Quintela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cadarso-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Tome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"9290_CR1","unstructured":"WHO Coronavirus (COVID19) Dashboard. Covid19.who.int. Access 11:53 CEST June-8-2021"},{"issue":"20","key":"9290_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson, S. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 323(20), 2052\u20132059 (2020).","journal-title":"JAMA"},{"issue":"3","key":"9290_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hep.31404","volume":"72","author":"MM Phipps","year":"2020","unstructured":"Phipps, M. M. et al. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort. Hepatology. 72(3), 807\u2013817 (2020).","journal-title":"Hepatology."},{"key":"9290_CR4","doi-asserted-by":"crossref","unstructured":"Popkin, B. M., et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes. Rev. 21(11),\u00a0e13128 (2020).","DOI":"10.1111\/obr.13128"},{"issue":"5","key":"9290_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2020.06.006","volume":"73","author":"D Jothimani","year":"2020","unstructured":"Jothimani, D., Venugopal, R., Abedin, M. F., Kaliamoorthy, I. & Rela, M. COVID-19 and the liver. J Hepatol. 73(5), 1231\u20131240 (2020).","journal-title":"J Hepatol."},{"issue":"3","key":"9290_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai, Q. et al. COVID-19: Abnormal liver function tests. J. Hepatol. 73(3), 566\u2013574 (2020).","journal-title":"J. Hepatol."},{"issue":"5","key":"9290_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/liv.14435","volume":"40","author":"LX Jia","year":"2020","unstructured":"Jia, L. X., Liu, M. L., Yang, D. & Zheng, X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 40(5), 998\u20131004 (2020).","journal-title":"Liver Int."},{"issue":"18","key":"9290_CR8","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.3390\/jcm10184222","volume":"10","author":"F Pa\u0161trovic","year":"2021","unstructured":"Pa\u0161trovic, F. et al. Prevalence: Experience from the regional COVID-19 center over the cohort of 3812 hospitalized patients. J. Clin. Med. 10(18), 4222 (2021).","journal-title":"J. Clin. Med."},{"issue":"6","key":"9290_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/liv.14470","volume":"40","author":"J Sun","year":"2020","unstructured":"Sun, J., Aghemo, A., Forner, A. & Valenti, L. COVID-19 and liver disease. Liver Int. 40(6), 1278\u20131281 (2020).","journal-title":"Liver Int."},{"key":"9290_CR10","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1111\/liv.14500","volume":"8","author":"CJ Pirola","year":"2020","unstructured":"Pirola, C. J. & Sookoian, S. SARS-CoV-2 virus and liver expression of host receptors: putative mechanismsof liver involvement in COVID-19. Liver Int. 8, 2038\u20132040 (2020).","journal-title":"Liver Int."},{"issue":"5","key":"9290_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","volume":"18","author":"T Marjot","year":"2021","unstructured":"Marjot, T. et al. COVID-19\u00a0and liver disease: mechanistic and clinical perspectives. Nat. Rev. Gastroenterol Hepatol. 18(5), 348\u2013364 (2021).","journal-title":"Nat. Rev. Gastroenterol Hepatol."},{"issue":"3","key":"9290_CR12","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/hep.31326","volume":"73","author":"PP Bloom","year":"2021","unstructured":"Bloom, P. P. et al. Liver biochemistries in hospitalized patients with COVID-19. Hepatology 73(3), 890\u2013900 (2021).","journal-title":"Hepatology"},{"issue":"2","key":"9290_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/hep.31301","volume":"72","author":"F Lei","year":"2020","unstructured":"Lei, F. et al. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology 72(2), 389\u2013398 (2020).","journal-title":"Hepatology"},{"key":"9290_CR14","doi-asserted-by":"publisher","first-page":"100554","DOI":"10.1016\/j.eclinm.2020.100554","volume":"27","author":"A Oussalah","year":"2020","unstructured":"Oussalah, A. et al. The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study. EClinicalMedicine. 27, 100554 (2020).","journal-title":"EClinicalMedicine."},{"issue":"23","key":"9290_CR15","first-page":"12536","volume":"24","author":"Q Li","year":"2020","unstructured":"Li, Q., Xu, W., Li, W. X., Huang, C. L. & Chen, L. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19. Eur. Rev. Med. Pharmacol. Sci. 24(23), 12536\u201312544 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"9290_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2147\/CIA.S303629","volume":"16","author":"W Xu","year":"2021","unstructured":"Xu, W., Huang, C., Fei, L., Li, Q. & Chen, L. Dynamic changes in liver function tests and their correlation with illness severity and mortality in patients with COVID-19: A retrospective cohort study. Clin Interv Aging. 16, 675\u2013685 (2021).","journal-title":"Clin Interv Aging."},{"key":"9290_CR17","unstructured":"World Health Organization. Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/laboratory-guidance."},{"issue":"7","key":"9290_CR18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ajg.2014.131","volume":"109","author":"NP Chalasani","year":"2014","unstructured":"Chalasani, N. P. et al. ACG Clinical Guideline: The diagnosis and management of idiosyncratic drug-induced liver injury. Am. J. Gastroenterol. 109(7), 950\u201366 (2014).","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"9290_CR19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani, R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. Ser. B (Methodol.) 58(1), 267\u2013288 (1996).","journal-title":"J. R. Stat. Soc. Ser. B (Methodol.)"},{"key":"9290_CR20","doi-asserted-by":"publisher","DOI":"10.1201\/9781315370279","volume-title":"Generalized additive models: an introduction with R","author":"SN Wood","year":"2017","unstructured":"Wood, S. N. Generalized additive models: an introduction with R (CRC Press, Boca Raton, 2017)."},{"key":"9290_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.csda.2017.03.004","volume":"112","author":"G Marra","year":"2017","unstructured":"Marra, G. & Radice, R. Bivariate copula additive models for location, scale and shape. Comput. Stat. Data Anal. 112, 99\u2013113 (2017).","journal-title":"Comput. Stat. Data Anal."},{"key":"9290_CR22","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2020","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, 2020)."},{"issue":"1","key":"9290_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jinf.2020.05.045","volume":"82","author":"SK Kunutsor","year":"2021","unstructured":"Kunutsor, S. K. & Laukkanen, J. A. Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis. J. Infect. 82(1), 159\u2013198 (2021).","journal-title":"J. Infect."},{"key":"9290_CR24","doi-asserted-by":"publisher","first-page":"100273","DOI":"10.1016\/j.aohep.2020.10.001","volume":"21","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. Liver disease and outcomes among COVID-19 hospitalized patients\u2014a systematic review and meta-analysis. Ann. Hepatol. 21, 100273 (2021).","journal-title":"Ann. Hepatol."},{"issue":"4","key":"9290_CR25","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/hep.31487","volume":"72","author":"MA Hundt","year":"2020","unstructured":"Hundt, M. A., Deng, Y., Ciarleglio, M. M., Nathanson, M. H. & Lim, J. K. Abnormal liver tests in COVID-19: A retrospective observational cohort study of 1,827 patients in a major U.S. Hospital network. Hepatology. 72(4), 1169\u20131176 (2020).","journal-title":"Hepatology."},{"key":"9290_CR26","doi-asserted-by":"crossref","unstructured":"Wang, D., et al.. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11), 1061\u20131069 (2020). Erratum in: JAMA. 2021;325(11):1113.","DOI":"10.1001\/jama.2020.1585"},{"issue":"18","key":"9290_CR27","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382(18), 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"9290_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.aohep.2020.05.001","volume":"4","author":"E Ridruejo","year":"2020","unstructured":"Ridruejo, E. & Soza, A. The liver in times of COVID-19: What hepatologists should know. Ann. Hepatol. 4, 353\u2013358 (2020).","journal-title":"Ann. Hepatol."},{"issue":"10","key":"9290_CR29","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/jmv.26036","volume":"92","author":"D Tian","year":"2020","unstructured":"Tian, D. & Ye, Q. Hepatic complications of COVID-19 and its treatment. J. Med. Virol. 92(10), 1818\u20131824 (2020).","journal-title":"J. Med. Virol."},{"issue":"16","key":"9290_CR30","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli, G. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. . JAMA 323(16), 1574\u20131581 (2020).","journal-title":"JAMA"},{"issue":"16","key":"9290_CR31","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jama.2020.4326","volume":"323","author":"M Arentz","year":"2020","unstructured":"Arentz, M. et al. Characteristics and outcomes of 21 critically Ill Patients with COVID-19 in Washington State. JAMA 323(16), 1612\u20131614 (2020).","journal-title":"JAMA"},{"issue":"1","key":"9290_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","volume":"146","author":"T Herold","year":"2020","unstructured":"Herold, T. et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J. Allergy Clin. Immunol. 146(1), 128\u2013136 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"9290_CR33","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","volume":"127","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 127, 104370 (2020).","journal-title":"J Clin Virol."},{"key":"9290_CR34","doi-asserted-by":"publisher","unstructured":"Ramasamy, M. N., et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial. Lancet 396(10267), 1979\u20131993 (2021). https:\/\/doi.org\/10.1016\/S0140-6736(20)32466-1. Epub 2020 Nov 19. Erratum in: Lancet. 2021 Dec 19;396(10267):1978. Erratum in: Lancet. 2021;397(10282):1350.","DOI":"10.1016\/S0140-6736(20)32466-1"},{"issue":"25","key":"9290_CR35","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson, E. J. et al. Beigel JH 2020 safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N. Engl. J. Med. 383(25), 2427\u20132438 (2020).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09290-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09290-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09290-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T12:31:41Z","timestamp":1726921901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09290-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9290"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09290-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5547"}}